Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction

Antioxidants and Redox Signaling

Volumn 18, Issue 6, 2013, Pages 630-641

  Montecucco, Fabrizio ^a   Bauer, Inga ^b   Braunersreuther, Vincent ^a   Bruzzone, Santina ^b   Akhmedov, Alexander ^c   Lüscher, Thomas F ^c   Speer, Timo ^c   Poggi, Alessandro ^d   Mannino, Elena ^b   Pelli, Graziano ^a   Galan, Katia ^a   Bertolotto, Maria ^b   Lenglet, Sébastien ^a   Garuti, Anna ^b   Montessuit, Christophe ^a   Lerch, René ^a   Pellieux, Corinne ^a   Vuilleumier, Nicolas ^a   Dallegri, Franco ^b   Mage, Jacqueline ^a   Sebastian, Carlos ^e   Mostoslavsky, Raul ^e   Gayet Ageron, Angèle ^a   Patrone, Franco ^b   MacH, François ^a   Nencioni, Alessio ^b   more..

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF GENOA   (Italy)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CXCL2 CHEMOKINE; DAPORINAD; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; SIRTUIN 6; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; EX VIVO STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL LINE; LIPID PEROXIDATION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION; REVIEW;

ACRYLAMIDES; ANIMALS; CHEMOKINE CXCL2; HUMANS; MALE; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NAD; NEUTROPHIL INFILTRATION; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDATIVE STRESS; PIPERIDINES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

MURINAE; MUS;

EID: 84872437664     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4487     Document Type: Review

References (36)

1. Beiser DG, Wang H, Li J, Wang X, Yordanova V, Das A, Mirzapoiazova T, Garcia JG, Stern SA, and Vanden Hoek TL. Plasma and myocardial visfatin expression changes are associated with therapeutic hypothermia protection during murine hemorrhagic shock/resuscitation. Resuscitation 81: 742-748, 2010.
2. Braunersreuther V, Mach F, and Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 97: 714-721, 2007. (Pubitemid 46804314)
3. Braunersreuther V, Pellieux C, Pelli G, Burger F, Steffens S, Montessuit C, Weber C, Proudfoot A, Mach F, and Arnaud C. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice. J Mol Cell Cardiol 48: 789-798, 2010.
4. Bruzzone S, Fruscione F, Morando S, Ferrando T, Poggi A, Garuti A, D'Urso A, Selmo M, Benvenuto F, Cea M, Zoppoli G, Moran E, Soncini D, Ballestrero A, Sordat B, Patrone F, Mostoslavsky R, Uccelli A, and Nencioni A. Catastrophic NAD+ depletion in activated T lymphocytes through NAMPT inhibition reduces demyelination and disability in EAE. PLoS One 4: e7897, 2009.
5. Busso N, Karababa M, Nobile M, Rolaz A, Van Gool F, Galli M, Leo O, So A, and De Smedt T. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One 3: e2267, 2008.
6. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, and Lee YJ. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91: 295-299, 2006. (Pubitemid 43069152)
7. Frangogiannis NG, Smith CW, and Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002. (Pubitemid 34020764)
8. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, and Shimomura I. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430, 2005. (Pubitemid 40139988)
9. Haider KH and Stimson WH. Cardiac troponin-I: A biochemical marker for cardiac cell necrosis. Dis Markers 11: 205-215, 1993. (Pubitemid 24171597)
10. Hasmann M and Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63: 7436-7442, 2003. (Pubitemid 37413486)
11. Hori M and Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 81: 457-464, 2009.
12. Hsu CP, Oka S, Shao D, Hariharan N, and Sadoshima J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res 105: 481-491, 2009.
13. Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S, and Sadoshima J. Silent information regulator 1 protects the heart from ischemia/ reperfusion. Circulation 122: 2170-2182, 2010.
14. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, Lander ES, and Hacohen N. The plasticity of dendritic cell responses to pathogens and their components. Science 294: 870-875, 2001. (Pubitemid 33032108)
15. Iqbal J and Zaidi M. TNF regulates cellular NAD+ metabolism in primary macrophages. Biochem Biophys Res Commun 342: 1312-1318, 2006.
16. Kaminski KA, Bonda TA, Korecki J, and Musial WJ. Oxidative stress and neutrophil activation - The two keystones of ischemia/reperfusion injury. Int J Cardiol 86: 41-59, 2002. (Pubitemid 35247882)
17. Lim SY, Davidson SM, Paramanathan AJ, Smith CC, Yellon DM, and Hausenloy DJ. The novel adipocytokine visfatin exerts direct cardioprotective effects. J Cell Mol Med 12: 1395-1403, 2008.
18. Liu SW, Qiao SB, Yuan JS, and Liu DQ. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans. Clin Endocrinol (Oxf) 71: 202-207, 2009.
19. Liu X, Ji Y, Chen J, Li S, and Luo F. Circulating visfatin in chronic obstructive pulmonary disease. Nutrition 25: 373-378, 2009.
20. 2616-2623, 2005.
21. Luk T, Malam Z, and Marshall JC. Pre-B cell colonyenhancing factor (NAMPT)/visfatin: A novel mediator of innate immunity. J Leukoc Biol 83: 804-816, 2008. (Pubitemid 351959859)
22. Martin PR, Shea RJ, and Mulks MH. Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence. J Bacteriol 183: 1168-1174, 2001. (Pubitemid 32107712)
23. McGlothlin JR, Gao L, Lavoie T, Simon BA, Easley RB, Ma SF, Rumala BB, Garcia JG, and Ye SQ. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochem Genet 43: 127-141, 2005. (Pubitemid 40543710)
24. Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, and Kawahara TL, Barrett JC, Chang HY, Bohr VA, Ried T, Gozani O, and Chua KF. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452: 492-496, 2008. (Pubitemid 351450840)
25. Miller TA and Schaefer FW 3rd. Changes in mouse circulating leukocyte numbers in C57BL/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production. Vet Parasitol 149: 147-157, 2007. (Pubitemid 47498748)
26. Montecucco F, Lenglet S, Braunersreuther V, Burger F, Pelli G, Bertolotto M, Mach F, and Steffens S. CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. J Mol Cell Cardiol 46: 612-620, 2009.
27. Montecucco F, Lenglet S, Braunersreuther V, Pelli G, Pellieux C, Montessuit C, Lerch R, Deruaz M, Proudfoot AE, and Mach F. Single administration of the CXC chemokinebinding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice. Arterioscler Thromb Vasc Biol 30: 1371-1377, 2010.
28. Pellieux C, Aasum E, Larsen TS, Montessuit C, Papageorgiou I, Pedrazzini T, and Lerch R. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. J Mol Cell Cardiol 41: 459-466, 2006. (Pubitemid 44344282)
29. Pittelli M, Formentini L, Faraco G, Lapucci A, Rapizzi E, Cialdai F, Romano G, Moneti G, Moroni F, and Chiarugi A. Inhibition of nicotinamide phosphoribosyltransferase: Cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J Biol Chem 285: 34106-34114, 2010.
30. Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, and Stein CM. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60: 1906-1914, 2009.
31. Rongvaux A, Galli M, Denanglaire S, Van Gool F, Drèze PL, Szpirer C, Bureau F, Andris F, and Leo O. Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress. J Immunol 181: 4685-4695, 2008.
32. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O, and Andris F. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 32: 3225-3234, 2002. (Pubitemid 35414880)
33. Samal B, Sun Y, Stearns G, Xie C, Suggs S, and McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14: 1431-1437, 1994.
34. Takagi H, Hsu CP, Kajimoto K, Shao D, Yang Y, Maejima Y, Zhai P, Yehia G, Yamada C, Zablocki D, and Sadoshima J. Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion. Circ Res 107: 642-649, 2010.
35. Van Gool F, Gallí M, Gueydan C, Kruys V, Prevot PP, Bedalov A, Mostoslavsky R, Alt FW, De Smedt T, and Leo O. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat Med 15: 206-210, 2009.
36. von Heideman A, Berglund A, Larsson R, and Nygren P. Safety and efficacy of NAD depleting cancer drugs: Results of a phase I clinical trial of CHS 828 and overview of published data. Cancer Chemother Pharmacol 65: 1165-1172, 2010.